These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22984506)

  • 1. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; McAteer JB; Franks PW; Mason CC; Mather K; Horton E; Goldberg R; Dabelea D; Kahn SE; Arakaki RF; Shuldiner AR; Knowler WC;
    PLoS One; 2012; 7(9):e44424. PubMed ID: 22984506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8 and IGF1 are associated with glucose metabolism in the Chinese.
    Hu C; Zhang R; Wang C; Wang J; Ma X; Hou X; Lu J; Yu W; Jiang F; Bao Y; Xiang K; Jia W
    PLoS One; 2010 Nov; 5(11):e15542. PubMed ID: 21103350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
    Hu C; Zhang R; Wang C; Yu W; Lu J; Ma X; Wang J; Jiang F; Tang S; Bao Y; Xiang K; Jia W
    PLoS One; 2010 Jul; 5(7):e11761. PubMed ID: 20668700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin.
    Wagner R; Dudziak K; Herzberg-Schäfer SA; Machicao F; Stefan N; Staiger H; Häring HU; Fritsche A
    PLoS One; 2011; 6(8):e23639. PubMed ID: 21887289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people.
    Boesgaard TW; Grarup N; Jørgensen T; Borch-Johnsen K; ; Hansen T; Pedersen O
    Diabetologia; 2010 Aug; 53(8):1647-55. PubMed ID: 20419449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
    Dupuis J; Langenberg C; Prokopenko I; Saxena R; Soranzo N; Jackson AU; Wheeler E; Glazer NL; Bouatia-Naji N; Gloyn AL; Lindgren CM; Mägi R; Morris AP; Randall J; Johnson T; Elliott P; Rybin D; Thorleifsson G; Steinthorsdottir V; Henneman P; Grallert H; Dehghan A; Hottenga JJ; Franklin CS; Navarro P; Song K; Goel A; Perry JR; Egan JM; Lajunen T; Grarup N; Sparsø T; Doney A; Voight BF; Stringham HM; Li M; Kanoni S; Shrader P; Cavalcanti-Proença C; Kumari M; Qi L; Timpson NJ; Gieger C; Zabena C; Rocheleau G; Ingelsson E; An P; O'Connell J; Luan J; Elliott A; McCarroll SA; Payne F; Roccasecca RM; Pattou F; Sethupathy P; Ardlie K; Ariyurek Y; Balkau B; Barter P; Beilby JP; Ben-Shlomo Y; Benediktsson R; Bennett AJ; Bergmann S; Bochud M; Boerwinkle E; Bonnefond A; Bonnycastle LL; Borch-Johnsen K; Böttcher Y; Brunner E; Bumpstead SJ; Charpentier G; Chen YD; Chines P; Clarke R; Coin LJ; Cooper MN; Cornelis M; Crawford G; Crisponi L; Day IN; de Geus EJ; Delplanque J; Dina C; Erdos MR; Fedson AC; Fischer-Rosinsky A; Forouhi NG; Fox CS; Frants R; Franzosi MG; Galan P; Goodarzi MO; Graessler J; Groves CJ; Grundy S; Gwilliam R; Gyllensten U; Hadjadj S; Hallmans G; Hammond N; Han X; Hartikainen AL; Hassanali N; Hayward C; Heath SC; Hercberg S; Herder C; Hicks AA; Hillman DR; Hingorani AD; Hofman A; Hui J; Hung J; Isomaa B; Johnson PR; Jørgensen T; Jula A; Kaakinen M; Kaprio J; Kesaniemi YA; Kivimaki M; Knight B; Koskinen S; Kovacs P; Kyvik KO; Lathrop GM; Lawlor DA; Le Bacquer O; Lecoeur C; Li Y; Lyssenko V; Mahley R; Mangino M; Manning AK; Martínez-Larrad MT; McAteer JB; McCulloch LJ; McPherson R; Meisinger C; Melzer D; Meyre D; Mitchell BD; Morken MA; Mukherjee S; Naitza S; Narisu N; Neville MJ; Oostra BA; Orrù M; Pakyz R; Palmer CN; Paolisso G; Pattaro C; Pearson D; Peden JF; Pedersen NL; Perola M; Pfeiffer AF; Pichler I; Polasek O; Posthuma D; Potter SC; Pouta A; Province MA; Psaty BM; Rathmann W; Rayner NW; Rice K; Ripatti S; Rivadeneira F; Roden M; Rolandsson O; Sandbaek A; Sandhu M; Sanna S; Sayer AA; Scheet P; Scott LJ; Seedorf U; Sharp SJ; Shields B; Sigurethsson G; Sijbrands EJ; Silveira A; Simpson L; Singleton A; Smith NL; Sovio U; Swift A; Syddall H; Syvänen AC; Tanaka T; Thorand B; Tichet J; Tönjes A; Tuomi T; Uitterlinden AG; van Dijk KW; van Hoek M; Varma D; Visvikis-Siest S; Vitart V; Vogelzangs N; Waeber G; Wagner PJ; Walley A; Walters GB; Ward KL; Watkins H; Weedon MN; Wild SH; Willemsen G; Witteman JC; Yarnell JW; Zeggini E; Zelenika D; Zethelius B; Zhai G; Zhao JH; Zillikens MC; ; ; ; Borecki IB; Loos RJ; Meneton P; Magnusson PK; Nathan DM; Williams GH; Hattersley AT; Silander K; Salomaa V; Smith GD; Bornstein SR; Schwarz P; Spranger J; Karpe F; Shuldiner AR; Cooper C; Dedoussis GV; Serrano-Ríos M; Morris AD; Lind L; Palmer LJ; Hu FB; Franks PW; Ebrahim S; Marmot M; Kao WH; Pankow JS; Sampson MJ; Kuusisto J; Laakso M; Hansen T; Pedersen O; Pramstaller PP; Wichmann HE; Illig T; Rudan I; Wright AF; Stumvoll M; Campbell H; Wilson JF; ; ; Bergman RN; Buchanan TA; Collins FS; Mohlke KL; Tuomilehto J; Valle TT; Altshuler D; Rotter JI; Siscovick DS; Penninx BW; Boomsma DI; Deloukas P; Spector TD; Frayling TM; Ferrucci L; Kong A; Thorsteinsdottir U; Stefansson K; van Duijn CM; Aulchenko YS; Cao A; Scuteri A; Schlessinger D; Uda M; Ruokonen A; Jarvelin MR; Waterworth DM; Vollenweider P; Peltonen L; Mooser V; Abecasis GR; Wareham NJ; Sladek R; Froguel P; Watanabe RM; Meigs JB; Groop L; Boehnke M; McCarthy MI; Florez JC; Barroso I
    Nat Genet; 2010 Feb; 42(2):105-16. PubMed ID: 20081858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans.
    Liu C; Li H; Qi L; Loos RJ; Qi Q; Lu L; Gan W; Lin X
    PLoS One; 2011; 6(6):e21464. PubMed ID: 21747906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
    Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
    PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
    Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM
    Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function.
    Staiger H; Machicao F; Schäfer SA; Kirchhoff K; Kantartzis K; Guthoff M; Silbernagel G; Stefan N; Häring HU; Fritsche A
    PLoS One; 2008; 3(12):e3962. PubMed ID: 19088850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.
    Wang H; Liu L; Zhao J; Cui G; Chen C; Ding H; Wang DW
    PLoS One; 2013; 8(6):e67665. PubMed ID: 23840762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study.
    Kelliny C; Ekelund U; Andersen LB; Brage S; Loos RJ; Wareham NJ; Langenberg C
    Diabetes; 2009 Dec; 58(12):2939-45. PubMed ID: 19741166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study.
    Renström F; Shungin D; Johansson I; ; Florez JC; Hallmans G; Hu FB; Franks PW
    Diabetes; 2011 Jan; 60(1):345-54. PubMed ID: 20870969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism.
    Pollin TI; Jablonski KA; McAteer JB; Saxena R; Kathiresan S; Kahn SE; Goldberg RB; Altshuler D; Florez JC;
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1142-7. PubMed ID: 21525158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations.
    Takeuchi F; Katsuya T; Chakrewarthy S; Yamamoto K; Fujioka A; Serizawa M; Fujisawa T; Nakashima E; Ohnaka K; Ikegami H; Sugiyama T; Nabika T; Kasturiratne A; Yamaguchi S; Kono S; Takayanagi R; Yamori Y; Kobayashi S; Ogihara T; de Silva A; Wickremasinghe R; Kato N
    Diabetologia; 2010 Feb; 53(2):299-308. PubMed ID: 19937311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations with modest effects have an important role in the genetic background of type 2 diabetes and diabetes-related traits.
    Fujita H; Hara K; Shojima N; Horikoshi M; Iwata M; Hirota Y; Tobe K; Seino S; Kadowaki T
    J Hum Genet; 2012 Dec; 57(12):776-9. PubMed ID: 22992776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility, lifestyle intervention and glycemic changes among women with prior gestational diabetes.
    Liang Z; Wang L; Liu H; Chen Y; Zhou T; Heianza Y; Leng J; Li W; Yang X; Shen Y; Gao R; Hu G; Qi L
    Clin Nutr; 2020 Jul; 39(7):2144-2150. PubMed ID: 31542245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
    Moore AF; Jablonski KA; McAteer JB; Saxena R; Pollin TI; Franks PW; Hanson RL; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
    Diabetes; 2008 Sep; 57(9):2503-10. PubMed ID: 18544707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes.
    Rees SD; Hydrie MZ; O'Hare JP; Kumar S; Shera AS; Basit A; Barnett AH; Kelly MA
    PLoS One; 2011; 6(9):e24710. PubMed ID: 21949744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program.
    Majithia AR; Jablonski KA; McAteer JB; Mather KJ; Goldberg RB; Kahn SE; Florez JC;
    Diabetologia; 2011 Oct; 54(10):2570-4. PubMed ID: 21779873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.